Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 312.50 | 200.50 | 170.00 | 313.25 | 0.5427 | -0.2261 |
| SK-BR-3 | 0 | uM | 9 | 312.50 | 200.50 | 238.00 | 313.25 | 0.7598 | 0.3052 | |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 846.00 | 884.25 | 0.9567 | 0.9206 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 625.00 | 414.82 | 855.00 | 884.25 | 0.9669 | 0.9393 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 482.00 | 884.25 | 0.5451 | 0.1474 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 625.00 | 414.82 | 765.00 | 884.25 | 0.8651 | 0.7515 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 625.00 | 414.82 | 952.00 | 884.25 | 1.0766 | 1.1399 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 625.00 | 414.82 | 759.00 | 884.25 | 0.8584 | 0.7389 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 625.00 | 414.82 | 756.00 | 884.25 | 0.8550 | 0.7326 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 625.00 | 414.82 | 923.00 | 884.25 | 1.0438 | 1.0801 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 1325.00 | 884.25 | 1.4984 | 1.8965 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 625.00 | 414.82 | 991.00 | 884.25 | 1.1207 | 1.2200 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 1076.00 | 884.25 | 1.2169 | 1.3938 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 427.00 | 884.25 | 0.4829 | 0.0269 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 625.00 | 414.82 | 1173.00 | 884.25 | 1.3265 | 1.5907 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 1030.00 | 884.25 | 1.1648 | 1.2999 | |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 625.00 | 414.82 | 973.00 | 884.25 | 1.1004 | 1.1831 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 625.00 | 414.82 | 446.00 | 884.25 | 0.5044 | 0.0686 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 625.00 | 414.82 | 753.00 | 884.25 | 0.8516 | 0.7263 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 625.00 | 414.82 | 359.00 | 884.25 | 0.4060 | -0.1240 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 766.00 | 884.25 | 0.8663 | 0.7536 | |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 911.00 | 884.25 | 1.0303 | 1.0553 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 625.00 | 414.82 | 927.00 | 884.25 | 1.0483 | 1.0884 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 771.00 | 884.25 | 0.8719 | 0.7641 | |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 901.00 | 884.25 | 1.0189 | 1.0347 |